<p>Human endothelial cells were treated with increasing concentrations of palmitate, linoleic acid, transvaccenic (<i>trans</i>-C18:1 (11 trans)), linoelaidic (<i>trans</i>-C18:2 (9 trans, 12 trans)), and elaidic (<i>trans</i>-C18:1 (9 trans)) for 3 h. All fatty acids were initially complexed with BSA and in the control condition cells were treated with BSA alone for 3 h. <b>A</b>. Phospho-IκBα levels were measured using an ELISA assay. Fold-increase over the control (BSA alone) condition was calculated. (n = 3, *p<0.05). <b>B</b>. IL-6 levels as measured by ELISA. (n = 3, * p<0.05). <b>C</b>. Expression levels of TNFα, ICAM, and iNOS in response to 100 µM of fat. (n = 3, * p<0.05).</p
Background and Aim: Endothelial activation is characterized by excessive production of cytokines and...
Endothelial dysfunction and inflammation are recognised factors in the development of atherosclerosi...
1 ScopeFatty acids (FAs) may affect endothelial cell (EC) function, influencing atherogenesis and in...
<p>Human endothelial cells were treated with either 100 µM of palmitate, linoleic acid, transvacceni...
<p>Human endothelial cells were treated with either 100 µM of palmitate, linoleic acid, transvacceni...
Polyunsaturated fatty acids (PUFA) are reported to exert prophylactic and acute therapeutic effects ...
Tissue factor (TF) is expressed on the endothelium in response to inflammatory mediators, giving end...
Background: Endothelial dysfunction may be related to adverse effects of some dietary fatty acids (F...
<p>Background and Aim: Endothelial activation is characterized by excessive production of cytokines ...
<p>Background and Aim: Endothelial activation is characterized by excessive production of cytokines ...
Endothelial dysfunction and inflammation are recognised factors in the development of atherosclerosi...
Endothelial activation is considered to be an early and critical event in the pathology of atherogen...
Background and Aim: Endothelial activation is characterized by excessive production of cytokines and...
Background and Aim: Endothelial activation is characterized by excessive production of cytokines and...
Background and Aim: Endothelial activation is characterized by excessive production of cytokines and...
Background and Aim: Endothelial activation is characterized by excessive production of cytokines and...
Endothelial dysfunction and inflammation are recognised factors in the development of atherosclerosi...
1 ScopeFatty acids (FAs) may affect endothelial cell (EC) function, influencing atherogenesis and in...
<p>Human endothelial cells were treated with either 100 µM of palmitate, linoleic acid, transvacceni...
<p>Human endothelial cells were treated with either 100 µM of palmitate, linoleic acid, transvacceni...
Polyunsaturated fatty acids (PUFA) are reported to exert prophylactic and acute therapeutic effects ...
Tissue factor (TF) is expressed on the endothelium in response to inflammatory mediators, giving end...
Background: Endothelial dysfunction may be related to adverse effects of some dietary fatty acids (F...
<p>Background and Aim: Endothelial activation is characterized by excessive production of cytokines ...
<p>Background and Aim: Endothelial activation is characterized by excessive production of cytokines ...
Endothelial dysfunction and inflammation are recognised factors in the development of atherosclerosi...
Endothelial activation is considered to be an early and critical event in the pathology of atherogen...
Background and Aim: Endothelial activation is characterized by excessive production of cytokines and...
Background and Aim: Endothelial activation is characterized by excessive production of cytokines and...
Background and Aim: Endothelial activation is characterized by excessive production of cytokines and...
Background and Aim: Endothelial activation is characterized by excessive production of cytokines and...
Endothelial dysfunction and inflammation are recognised factors in the development of atherosclerosi...
1 ScopeFatty acids (FAs) may affect endothelial cell (EC) function, influencing atherogenesis and in...